Table 2.
Prevalence of the HPV+ among the individuals with disease.
| Disease | HPV+ | |||||||
|---|---|---|---|---|---|---|---|---|
| HPV+ | Single HPV+ | Double HPV+ | Triple HPV+ | |||||
| No. | Ratio | No. | Ratio | No. | Ratio | No. | Ratio | |
| Control | 61 | 14.3% | 44 | 10.3% | 10 | 2.3% | 7 | 1.6% |
| Pelvic | 45 | 18.8% | 30 | 12.6% | 8 | 3.3% | 7 | 2.9% |
| CL | 264 | 40.1% | 199 | 30.2% | 46 | 7.0% | 19 | 2.9% |
| FV | 57 | 18.8% | 46 | 15.1% | 4 | 1.3% | 7 | 2.3% |
| BV | 216 | 22.9% | 149 | 15.8% | 47 | 4.9% | 21 | 2.2% |
The ratio is calculated by the total HPV positive, the single HPV positive, double HPV positive or triple HPV positive individuals, divided the total infected individuals respectively.
BV = bacterial vaginitis, CL= cervical lesions, FV=fungal vaginitis, No. = sample number.